By Counterforce Health Team in Elelyso (taliglucerase alfa) —

How to Get Elelyso (Taliglucerase Alfa) Covered by Humana in Virginia: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Elelyso (Taliglucerase Alfa) Covered by Humana in Virginia

Fastest path to approval: Have your specialist submit a prior authorization request with confirmed Gaucher disease Type 1 diagnosis (enzyme assay or genetic testing), clinical evidence of disease manifestations, and medical necessity documentation. If denied, you have 65 days to appeal through Humana's internal process, then 120 days for Virginia's free external review using Form 216-A. Start today: Contact your prescribing physician to initiate the PA request through Humana's provider portal.

Table of Contents

  1. Understanding Elelyso Coverage Requirements
  2. Reading Your Humana Denial Letter
  3. Common Denial Reasons and Quick Fixes
  4. Step-by-Step: Fastest Path to Approval
  5. Medical Necessity Letter Requirements
  6. Humana Appeals Process in Virginia
  7. Virginia External Review Process
  8. Templates and Scripts
  9. Cost-Saving Options
  10. When to Escalate
  11. FAQ

Understanding Elelyso Coverage Requirements

Elelyso (taliglucerase alfa) is an FDA-approved enzyme replacement therapy for Type 1 Gaucher disease in patients 4 years and older. Manufactured by Pfizer, this IV medication typically costs around $839-$899 per 200-unit vial, making prior authorization nearly universal among insurers.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Humana plans Humana PA Search Tool Humana Provider
Confirmed GD1 Diagnosis Enzyme assay or genetic testing Lab results, genetic report FDA Label
Specialist Prescriber Hematologist, endocrinologist, or geneticist Provider credentials Insurance policies
Clinical Evidence Anemia, thrombocytopenia, bone disease, or organomegaly Chart notes, labs, imaging Medical records
Appeals Deadline 65 days from denial notice Denial letter Humana Member Rights

Reading Your Humana Denial Letter

When Humana denies Elelyso coverage, your denial letter will contain crucial information:

Key sections to identify:

  • Denial reason code (medical necessity, non-formulary, step therapy)
  • Appeal deadline (65 calendar days from the denial date)
  • Required documentation for appeals
  • Benefit type (Medicare Part B vs. Part D)
Tip: Elelyso is typically covered under Medicare Part B (medical benefit) since it's an IV infusion, not Part D (prescription drug benefit).

Common Denial Reasons and Quick Fixes

Denial Reason How to Overturn Required Documents
Lack of confirmed diagnosis Submit enzyme assay or genetic testing Lab results showing β-glucocerebrosidase deficiency
Insufficient clinical evidence Document disease manifestations CBC, liver/spleen imaging, bone studies
Step therapy required Request exception or document contraindications Prior therapy records, adverse event notes
Non-specialist prescriber Transfer to appropriate specialist Referral to hematologist/endocrinologist
Dosing outside FDA label Adjust to 60 U/kg every 2 weeks Updated prescription

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation (Patient/Family)

  • Insurance card and member ID
  • Complete medical records for Gaucher disease
  • Lab results confirming diagnosis
  • Prior therapy history (if any)

2. Specialist Consultation (Physician)

  • Confirm Type 1 Gaucher disease diagnosis
  • Document clinical manifestations
  • Submit prior authorization request via Humana provider portal
  • Timeline: 7-30 days for decision

3. If Denied: Request Peer-to-Peer Review (Physician)

  • Contact Humana medical director
  • Present clinical evidence directly
  • Timeline: Usually scheduled within 5-7 business days

4. File Internal Appeal (Patient/Physician)

  • Submit within 65 days of denial
  • Include medical necessity letter
  • Timeline: 30 days for standard, 72 hours for expedited

5. External Review (Patient)

  • File with Virginia Bureau of Insurance
  • Use Form 216-A within 120 days of final denial
  • Timeline: 45 days for standard, 72 hours for expedited

Medical Necessity Letter Requirements

Your prescribing physician must include specific elements in the medical necessity documentation:

Essential components:

  • Confirmed diagnosis: "Patient has Type 1 Gaucher disease confirmed by [enzyme assay/genetic testing] showing [specific results]"
  • Clinical manifestations: Document at least one of:
    • Anemia (hemoglobin < 11 g/dL)
    • Thrombocytopenia (platelet count < 100,000/µL)
    • Bone disease or fractures
    • Hepatosplenomegaly
  • Treatment rationale: "Enzyme replacement therapy is medically necessary to prevent disease progression and improve clinical outcomes"
  • Contraindications: If step therapy is required, document why preferred agents aren't suitable
Clinician Corner: Include ICD-10 code E75.22 (Gaucher disease) and reference FDA prescribing information. Cite current treatment guidelines supporting ERT for symptomatic Type 1 Gaucher disease.

Humana Appeals Process in Virginia

Internal Appeals

  • Who can appeal: Patient, authorized representative, or prescribing physician
  • Timeline: 65 days from denial notice
  • Decision timeframe: 30 days standard, 72 hours expedited
  • Required documentation: Medical necessity letter, supporting clinical evidence
  • How to submit: Humana member portal or mail to address on denial letter

Expedited Appeals

Request expedited review if waiting could seriously harm your health. Your physician must certify the urgency and complete required forms.

Virginia External Review Process

If Humana upholds the denial, Virginia offers free external review through the State Corporation Commission Bureau of Insurance.

Filing Requirements

  • Deadline: 120 days from final internal appeal decision
  • Form: Form 216-A External Review Request
  • Cost: Free to patients
  • Decision timeline: 45 days standard, 72 hours expedited

Required Documentation

  • Final denial letter from Humana
  • Medical records supporting your claim
  • Form 216-A completed and signed
  • Form 216-C (if requesting expedited review)

Submit to: Virginia Bureau of Insurance Life & Health Consumer Services P.O. Box 1157 Richmond, VA 23218 Phone: 1-877-310-6560

Note: Virginia's external review decision is binding on both you and Humana. If overturned, Humana must provide coverage within 1-3 days.

Templates and Scripts

Patient Phone Script for Humana

"I'm calling about a prior authorization denial for Elelyso (taliglucerase alfa) for my Type 1 Gaucher disease. My member ID is [number]. I'd like to request a peer-to-peer review with the medical director and understand my appeal options. Can you also confirm if this requires step therapy and what documentation is needed?"

Medical Necessity Letter Template

"[Patient name] has confirmed Type 1 Gaucher disease diagnosed by [enzyme assay/genetic testing] on [date]. Clinical manifestations include [list specific findings with lab values]. Current symptoms significantly impact quality of life with [describe functional limitations]. Enzyme replacement therapy with Elelyso is medically necessary as [explain rationale]. Alternative therapies are contraindicated due to [list reasons if applicable]. This treatment aligns with FDA labeling and current clinical guidelines for Type 1 Gaucher disease management."

Cost-Saving Options

Manufacturer Support

  • Pfizer GPS Support: Provides coverage assistance and copay support
  • Contact: Visit Elelyso.com support or call patient services
  • Eligibility: Income and insurance-based requirements

Additional Resources

  • National Organization for Rare Disorders (NORD): Rare disease patient assistance programs
  • Gaucher Disease Foundation: Educational resources and support networks

When to Escalate

Contact Virginia regulators if you experience:

  • Repeated denials without proper review
  • Missed appeal deadlines by Humana
  • Procedural violations during the appeals process

Virginia Bureau of Insurance Consumer Services Phone: 1-877-310-6560 File a complaint online or mail to the Richmond address above.

FAQ

Q: How long does Humana prior authorization take for Elelyso in Virginia? A: Standard PA decisions take 7-30 days. Expedited requests (with physician certification of urgency) are decided within 72 hours.

Q: What if Elelyso isn't on Humana's formulary? A: You can request a formulary exception with medical justification. Your physician must demonstrate why covered alternatives aren't suitable.

Q: Can I request expedited appeal in Virginia? A: Yes, both Humana internal appeals and Virginia external reviews offer expedited timelines (72 hours) when your physician certifies that delays could harm your health.

Q: Does step therapy apply if I've tried other ERTs outside Virginia? A: Previous therapy trials from any location count toward step therapy requirements. Provide documentation of prior treatments and outcomes.

Q: What counts as medical necessity for Elelyso? A: Confirmed Type 1 Gaucher disease with clinical evidence of disease impact (anemia, low platelets, bone disease, or organ enlargement) requiring enzyme replacement therapy.

Q: Can family members file appeals on my behalf? A: Yes, with proper authorization. Complete Humana's authorized representative form to allow family members to act on your behalf.

When traditional insurance channels aren't working, specialized platforms like Counterforce Health help patients and clinicians turn denials into targeted, evidence-backed appeals. By ingesting denial letters, plan policies, and clinical notes, these services identify the specific denial basis and draft point-by-point rebuttals aligned to the plan's own rules, potentially saving weeks in the appeals process.

The path to getting Elelyso covered by Humana in Virginia requires persistence and proper documentation, but Virginia's robust external review process provides a valuable safety net when internal appeals fail. With confirmed diagnosis, clinical evidence, and proper appeals procedures, many patients successfully obtain coverage for this essential treatment.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about treatment decisions and contact qualified professionals for legal guidance on insurance matters.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.